In-hospital case-fatality after intracerebral hemorrhage in southern Iran: a single-center retrospective study Authors: Amirreza Radfar, AmirAli Rastegar Kazerooni, Mohammad Sadegh Masoudi, MohammadReza Zakeri Published: 2026 ABSTRACT BackgroundIntracerebral hemorrhage (ICH) is a life-threatening form of stroke associated with high morbidity and in-hospital case-fatality, particularly in low- and middle-income countries. This study aimed to identify clinical factors associated with in-hospital case-fatality among patients with ICH in southern Iran.MethodsThis retrospective observational study included patients with ICH admitted to Namazi Hospital, a high-volume tertiary referral center in southern Iran, between March 2018 and February 2021. Demographic characteristics, comorbidities, and in-hospital outcomes were extracted from electronic medical records. The primary outcome was in-hospital case-fatality, defined as death during the index hospitalization. Statistical analyses included independent-samples t-tests, chi-square tests, and multivariable logistic regression to identify factors independently associated with in-hospital case-fatality.ResultsA total of 1,796 patients were included in the final analysis. Patients who died during hospitalization were older than survivors (64.6 ± 20.4 vs. 60.3 ± 20.7 years, p < 0.001). Sex, place of residence, and length of hospital stay did not differ significantly between groups in unadjusted analyses. Comorbid conditions, including hypertension, diabetes mellitus, chronic kidney disease, cardiovascular disease, malignancy, and COVID-19 infection, were more frequent among non-survivors (all p < 0.001). In multivariable analysis, diabetes mellitus (OR 3.46, 95% CI 1.40–8.55), hypertension (OR 4.76, 95% CI 3.62–6.27), chronic kidney disease (OR 6.98, 95% CI 3.00–16.27), cardiovascular disease (OR 7.15, 95% CI 4.42–11.57), malignancy (OR 8.83, 95% CI 4.21–18.55), and COVID-19 infection (OR 7.21, 95% CI 3.24–16.08) were independently associated with increased odds of in-hospital case-fatality.ConclusionIn this cohort of patients with ICH, several comorbid conditions were independently associated with in-hospital case-fatality. These findings may support early risk stratification in similar resource-limited settings. Further studies incorporating detailed clinical severity measures are warranted to improve risk prediction and interpretation.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12883-026-05059-1. Introduction Stroke is a major public health concern and ranks as the second leading cause of death and disability worldwide. Hemorrhagic stroke accounts for approximately 15% of all stroke cases but is associated with the highest rates of mortality and morbidity among stroke subtypes [1]. Among these, intracerebral hemorrhage (ICH), defined as bleeding directly into the brain parenchyma, represents a particularly devastating clinical entity with limited treatment options and poor outcomes [2, 3]. Globally, the incidence of ICH is estimated at 24.6 per 100,000 individuals, with approximately two million new cases reported annually [4, 5]. Despite advances in neurocritical care, short-term outcomes remain poor, with reported 30-day survival rates ranging from 48% to 65%, and nearly half of deaths occurring within the first 24 h of symptom onset [5]. Long-term recovery is also limited, with fewer than 20% of survivors achieving functional independence at six months. These challenges are particularly pronounced in low- and middle-income countries (LMICs), where the incidence of ICH is nearly double that observed in high-income settings and access to specialized stroke care is often limited [6]. Multiple studies have identified key risk factors for ICH, including hypertension, advanced age, male sex, alcohol consumption, anticoagulant use, and low serum cholesterol levels. In contrast, etiological mechanisms such as cerebral amyloid angiopathy and macrovascular lesions represent underlying disease causes rather than modifiable risk factors [3, 7–9]. In addition to patient-level characteristics, health system– and hospital-level factors, including time to hospital presentation, availability of specialized resources, geographic distance from care facilities, and the quality of inpatient care, play a critical role in determining ICH outcomes [10, 11]. The prognostic impact of comorbid conditions such as diabetes mellitus, chronic kidney disease, cardiovascular disease, and systemic malignancies has also been consistently reported [9, 12, 13]. While predictors of ICH outcomes have been extensively studied in high-income countries, data from LMICs, particularly from Middle Eastern populations, remain limited. Regional disparities in healthcare infrastructure, referral pathways, and access to acute stroke services highlight the need for context-specific evidence to inform early risk stratification and clinical decision-making [6, 14]. Notably, the study period included both pre-pandemic and pandemic phases, during which healthcare system disruptions related to the COVID-19 pandemic may have influenced in-hospital outcomes [15]. Namazi Hospital, located in Shiraz, is a major tertiary neurology and neurosurgical referral center serving southern Iran and neighboring regions, providing comprehensive emergency and inpatient stroke care within a resource-constrained setting. This context offers a valuable opportunity to evaluate real-world clinical outcomes among patients with ICH. Accordingly, the present study aimed to identify demographic and clinical factors associated with in-hospital case-fatality among patients admitted with ICH between 2018 and 2021, with the goal of informing early risk assessment and inpatient management strategies in similar LMIC settings. Methods Study design, setting, and population This retrospective observational study of a consecutive case series was conducted at Namazi Hospital, a major tertiary neurosurgical and neurology referral center in southern Iran affiliated with Shiraz University of Medical Sciences. The study included patients admitted with a confirmed diagnosis of ICH between March 21, 2018, and February 27, 2021. All patients with ICH, including both spontaneous and traumatic cases, were initially assessed for eligibility. Records were included if they contained complete data on key study variables, including age, sex, length of hospital stay, place of residence, comorbidities, and in-hospital outcome. Records were excluded if they were duplicated, incomplete, or if the final diagnosis was not consistent with ICH. Duplicate records reflected repeated admissions or administrative duplications and were removed to ensure patient-level analysis. A complete-case analysis was performed, and no imputation was applied for missing data. The study flow is presented in Fig. 1. Fig. 1Flowchart of patient inclusion and exclusion Flowchart of patient inclusion and exclusion From an initial pool of 1,869 records, 1,796 patients with complete and valid data were included in the final analysis. Dates originally recorded in the Persian (Shamsi) calendar were converted to the Gregorian calendar to ensure consistency in reporting. Ethical approval The study was approved by the Ethics Committee of Shiraz University of Medical Sciences (approval code: IR.SUMS.MED.REC.1400.519). All procedures were conducted in accordance with the Declaration of Helsinki and the ethical guidelines of the Iranian Ministry of Health. Data collection and variables A standardized data extraction form was developed in Microsoft Excel (2019) based on previously published literature [16]. Patient records were retrieved from the hospital’s electronic medical record system and cross-verified using unique identifiers, including name, national identification number, and hospital file number, to enhance data accuracy. Extracted variables included demographic characteristics (age, sex, residence within Fars Province versus outside Fars Province), clinical comorbidities (hypertension, diabetes mellitus, chronic kidney disease, cardiovascular disease, malignancy, and COVID-19 infection), and hospitalization characteristics (length of hospital stay and in-hospital outcome). Age was recorded in years, and length of hospital stay in days. Comorbidities were treated as binary variables based on documentation in the electronic medical record. The primary outcome was in-hospital case-fatality, defined as death occurring during the index hospitalization, as documented in the medical record. Statistical analysis All analyses were performed using SPSS version 22. Continuous variables were expressed as mean ± standard deviation and compared between survivors and non-survivors using the independent-samples t-test. Categorical variables were presented as frequencies and percentages and compared using the chi-square test. To identify factors independently associated with in-hospital case-fatality, multivariable logistic regression analysis was performed with in-hospital death (yes/no) as the dependent variable, using a forced-entry approach. Independent variables included age, sex, place of residence, length of hospital stay, hypertension, diabetes mellitus, chronic kidney disease, cardiovascular disease, malignancy, and COVID-19 infection, selected based on clinical relevance and data availability. Results are reported as odds ratios (ORs) with 95% confidence intervals (CIs). A p-value < 0.05 was considered statistically significant. Multicollinearity among independent variables was assessed using variance inflation factors (VIF), with all variables demonstrating low collinearity. Results Baseline characteristics A total of 1,796 patients with ICH were included in the study, and the baseline demographic and clinical characteristics of the overall cohort, survivors, and non-survivors are presented in Table 1. The mean age of the overall cohort was 61.7 ± 20.7 years. Non-survivors were significantly older than survivors (64.6 ± 20.4 vs. 60.3 ± 20.7 years, p < 0.001). There were no statistically significant differences between survivors and non-survivors with respect to male sex (55.9% vs. 59.9%, p = 0.12), residence outside Fars Province (4.9% vs. 5.8%, p = 0.491), or length of hospital stay (9.3 ± 15.7 vs. 8.9 ± 13.2 days, p = 0.588). Table 1Baseline demographic and clinical characteristics of the overall cohort, survivors, and non-survivorsVariableOverall cohort (n = 1,796)Survivors (n = 1,204)Non-survivors (n = 592)p-valueAge, years61.7 ± 20.760.3 ± 20.764.6 ± 20.4< 0.001Male sex1,052 (58.6%)721 (59.9%)331 (55.9%)0.12Residence outside Fars Province99 (5.5%)70 (5.8%)29 (4.9%)0.491Length of hospital stay, days9.0 ± 14.18.9 ± 13.29.3 ± 15.70.588Hypertension321 (17.9%)113 (9.4%)208 (35.1%)< 0.001Diabetes mellitus39 (2.2%)7 (0.6%)32 (5.4%)< 0.001Chronic kidney disease39 (2.2%)8 (0.7%)31 (5.2%)< 0.001Cardiovascular disease120 (6.7%)25 (2.1%)95 (16.0%)< 0.001Malignancy41 (2.3%)10 (0.8%)31 (5.2%)< 0.001COVID-19 infection36 (2.0%)9 (0.7%)27 (4.6%)< 0.001 Table 1Baseline demographic and clinical characteristics of the overall cohort, survivors, and non-survivorsVariableOverall cohort (n = 1,796)Survivors (n = 1,204)Non-survivors (n = 592)p-valueAge, years61.7 ± 20.760.3 ± 20.764.6 ± 20.4< 0.001Male sex1,052 (58.6%)721 (59.9%)331 (55.9%)0.12Residence outside Fars Province99 (5.5%)70 (5.8%)29 (4.9%)0.491Length of hospital stay, days9.0 ± 14.18.9 ± 13.29.3 ± 15.70.588Hypertension321 (17.9%)113 (9.4%)208 (35.1%)< 0.001Diabetes mellitus39 (2.2%)7 (0.6%)32 (5.4%)< 0.001Chronic kidney disease39 (2.2%)8 (0.7%)31 (5.2%)< 0.001Cardiovascular disease120 (6.7%)25 (2.1%)95 (16.0%)< 0.001Malignancy41 (2.3%)10 (0.8%)31 (5.2%)< 0.001COVID-19 infection36 (2.0%)9 (0.7%)27 (4.6%)< 0.001 Baseline demographic and clinical characteristics of the overall cohort, survivors, and non-survivors In contrast, several comorbid conditions were significantly more frequent among non-survivors. Hypertension was present in 35.1% of non-survivors compared with 9.4% of survivors (p < 0.001). Diabetes mellitus was observed in 5.4% versus 0.6% (p < 0.001), chronic kidney disease in 5.2% versus 0.7% (p < 0.001), cardiovascular disease in 16.0% versus 2.1% (p < 0.001), malignancy in 5.2% versus 0.8% (p < 0.001), and COVID-19 infection in 4.6% versus 0.7% (p < 0.001). Multivariable logistic regression analysis Multivariable logistic regression analysis identified several comorbid conditions as independently associated with increased in-hospital case-fatality (Table 2). Diabetes mellitus was associated with higher odds of in-hospital death (OR 3.46, 95% CI 1.40–8.55, p = 0.007). Hypertension was also independently associated with mortality (OR 4.76, 95% CI 3.62–6.27, p < 0.001). Similarly, chronic kidney disease (OR 6.98, 95% CI 3.00–16.27, p < 0.001), COVID-19 infection (OR 7.21, 95% CI 3.24–16.08, p < 0.001), malignancy (OR 8.83, 95% CI 4.21–18.55, p < 0.001), and cardiovascular disease (OR 7.15, 95% CI 4.42–11.57, p < 0.001) were independently associated with higher odds of in-hospital case-fatality. Age was also significantly associated with mortality (OR 1.01, 95% CI 1.00–1.02, p < 0.001), whereas sex, province, and length of hospital stay were not significantly associated with in-hospital case-fatality. Variance inflation factor analysis demonstrated no evidence of multicollinearity among variables included in the multivariable model (mean VIF = 1.04; Table S1). Table 2Multivariable logistic regression analysis of factors associated with in-hospital case-fatalityVariableOdds Ratio95% CIP valueAge1.011.00–1.02< 0.001Gender0.860.71–1.050.147Province0.970.62–1.530.895Length of Stay10.98–1.010.382Hypertension4.763.62–6.27< 0.001Diabetes mellitus3.461.40–8.550.007Chronic kidney disease6.983.00–16.27< 0.001Cardiovascular disease7.154.42–11.57< 0.001Malignancy8.834.21–18.55< 0.001COVID-19 infection7.213.24–16.08< 0.001 Table 2Multivariable logistic regression analysis of factors associated with in-hospital case-fatalityVariableOdds Ratio95% CIP valueAge1.011.00–1.02< 0.001Gender0.860.71–1.050.147Province0.970.62–1.530.895Length of Stay10.98–1.010.382Hypertension4.763.62–6.27< 0.001Diabetes mellitus3.461.40–8.550.007Chronic kidney disease6.983.00–16.27< 0.001Cardiovascular disease7.154.42–11.57< 0.001Malignancy8.834.21–18.55< 0.001COVID-19 infection7.213.24–16.08< 0.001 Multivariable logistic regression analysis of factors associated with in-hospital case-fatality Discussion This study provides an analysis of in-hospital outcomes among patients with ICH admitted to a high-volume tertiary referral center in southern Iran over a three-year period. In our cohort, non-survivors were older than survivors, while sex, place of residence, and length of hospital stay were not significantly associated with in-hospital case-fatality. In multivariable analysis, hypertension, diabetes mellitus, chronic kidney disease, cardiovascular disease, malignancy, and COVID-19 infection were independently associated with higher odds of in-hospital death. These findings suggest that systemic comorbid conditions may contribute to short-term in-hospital outcomes in this setting. Age has been consistently reported as a major determinant of ICH outcomes in prior studies, including the work by Jolink et al. and Lu et al., which demonstrated increased case-fatality with advancing age [17, 18]. However, direct comparison with our findings requires caution, as many previous studies incorporated both in-hospital and out-of-hospital deaths, whereas our analysis was restricted to in-hospital case-fatality. Differences in case mix, referral patterns, and early pre-hospital mortality may therefore partially explain the observed discrepancies. Although male patients constituted the majority of ICH admissions in our study, consistent with earlier epidemiological studies [19, 20], we did not observe a consistent sex-based difference in in-hospital case-fatality. While some investigations have reported higher fatality rates among female patients [21], sex was not significantly associated with in-hospital death in our cohort. This may suggest that, in this setting, short-term in-hospital outcomes were more closely related to age and comorbid clinical status than to sex alone. Geographic residence has been discussed in relation to potential system-level factors such as access to specialized care, referral pathways, and potential delays in presentation. Although a proportion of patients were referred from outside Fars Province, residence was not significantly associated with in-hospital case-fatality in the final comparison. However, the potential role of pre-hospital delays could not be assessed. Prior studies have reported that a substantial proportion of ICH-related deaths occur within the first 24 h of symptom onset [5], emphasizing the critical role of timely diagnosis, rapid transfer, and early specialized care. Therefore, the influence of system-level factors such as referral efficiency and timely access to specialized care cannot be determined from the present data and should be interpreted cautiously. Comorbid medical conditions were strongly associated with increased in-hospital case-fatality in our study, in line with previous reports [22, 23]. Hypertension and diabetes mellitus were the most prevalent comorbidities, while CKD and malignancy conferred particularly high odds of death. Malignancy may increase hemorrhagic risk through tumor-related vascular fragility, coagulopathies, or treatment-associated complications, including chemotherapy and anticoagulation [24–27]. Cardiovascular disease also emerged as a significant predictor, consistent with earlier evidence linking cardiac comorbidities to poorer post-ICH outcomes [28]. COVID-19 infection was independently associated with increased in-hospital case-fatality. Although data on COVID-19–associated ICH remain limited, prior reviews by Cheruiyot et al. and Margos et al. have reported similarly poor outcomes, especially among older patients with multiple comorbidities or those receiving anticoagulation therapy [29–31]. The interplay of systemic inflammation, endothelial dysfunction, and anticoagulant exposure likely contributes to both the occurrence and fatal progression of ICH in this population. Although several of the identified predictors are well established in the literature, most available evidence is derived from high-income countries or older datasets. Contemporary data from low- and middle-income settings, particularly from the Middle East, remain limited. In this context, our study provides updated, region-specific evidence from a large cohort of patients treated in a tertiary referral center in southern Iran, reflecting current clinical practice, comorbidity profiles, and healthcare system conditions. Importantly, the absence of key hemorrhage severity variables, which are among the strongest predictors of outcome in ICH, should be considered when interpreting the strength of the observed associations. Furthermore, the inclusion of both pre-pandemic and COVID-19 periods allows additional insight into outcome patterns under varying healthcare system pressures. This study has several limitations that should be acknowledged. First, the retrospective design introduces the potential for selection and information bias, despite the inclusion of consecutive eligible cases with available records. Second, reliance on electronic medical records limited the availability of key hemorrhage-specific prognostic variables, including hematoma volume, hematoma location, intraventricular extension, hydrocephalus, and standardized stroke severity measures. The absence of these critical variables represents an important source of unmeasured confounding and substantially limits risk adjustment; accordingly, established severity scoring systems such as the ICH score could not be calculated. Third, etiologic classification of ICH was not systematically available in a structured format, limiting assessment of underlying causes and introducing potential clinical heterogeneity. In addition, the inclusion of both spontaneous and traumatic ICH may have introduced additional variability in outcomes and affected internal validity. Fourth, treatment-related variables, including neurosurgical interventions, intensive care unit management, and ventilatory support, were not consistently available in sufficient detail for robust adjustment, which may have introduced additional confounding related to acute management strategies. Finally, as a single-center study conducted at a tertiary referral hospital in southern Iran, the findings may have limited generalizability to other populations and healthcare settings. Conclusion In this cohort of patients with ICH, several comorbid conditions, including hypertension, diabetes mellitus, chronic kidney disease, cardiovascular disease, malignancy, and COVID-19 infection, were associated with higher in-hospital case-fatality. These findings may assist in risk stratification in similar resource-limited settings. However, interpretation of these associations should consider the retrospective design and the absence of key clinical severity variables, which introduce substantial unmeasured confounding and limit causal inference. Supplementary Information Supplementary Material 1. Supplementary Material 1.